Trials / Unknown
UnknownNCT03927807
Oral Misoprostol Solution in Labor Induction
A Comparison of the Efficacy and Safety of Repetitive Hourly Dose of Oral Misoprostol and Two Hourly Dose Oral Regimens for Cervical Ripening and Labor Induction
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study compares safety and efficacy between repetitive hourly dose of oral misoprostol and two hourly dose oral regimens for cervical ripening and labor induction.
Detailed description
Misoprostol is an effective agent for the induction of labor.existing guidelines recommend oral misoprostol solution every two hours.However,more research is required to optimize the use of oral misoprostol solution for labor induction.The current study is to compare efficacy and safety of repetitive hourly dose of oral misoprostol solution with two hourly dose of oral misoprostol solution for cervical ripening and labor induction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol | This study will include 150 pregnant women who fulfill the inclusion criteria and will be subdivided in two groups. Group1 will receive repetitive hourly dose of oral misoprostol solution equal to 10 microgram up to 12 doses or regular uterine activity. Group2 will receive oral misoprostol solution every two hours as 20 microgram up to 6 doses or regular uterine activity. |
Timeline
- Start date
- 2019-03-18
- Primary completion
- 2019-12-18
- Completion
- 2020-01-18
- First posted
- 2019-04-25
- Last updated
- 2019-04-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03927807. Inclusion in this directory is not an endorsement.